Skip to content
healthcare.dev

Lubiprostone

NDC 0254-3029, Lubiprostone, capsule, gelatin coated, from Par Health USA, LLC.

Product NDC
0254-3029
Status
Listed
Labeler
Par Health USA, LLC
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021908
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0254-3029 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE24 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package
0254-3029-020025430290260 CAPSULE, GELATIN COATED in 1 BOTTLE (0254-3029-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9d958b58-6c4f-4bb1-8660-cf5eac256440
  • NADAC price for package 00254302902

    GET /v1/drugs/nadac/00254302902

Use it

Look up 0254-3029 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0254-3029 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0254-3029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.